Results 31 to 40 of about 4,655,222 (236)

Factor Xa inhibitor for venous thromboembolism management in patient with cancer: a systematic review and meta-analysis [version 1; peer review: 2 approved]

open access: yesF1000Research, 2021
Background: An earlier systematic review reported no differences in the incidence of recurrent venous thromboembolism and major bleeding between factor Xa inhibitors and standard anticoagulation.
Ardyan Wardhana   +4 more
doaj   +1 more source

Prediction of inhibition constants of (R)-3-amidinophenylalanine inhibitors toward factor Xa by 2D-QSAR model

open access: yesVietnam Journal of Science, Technology and Engineering, 2022
A coagulation cascade forms through proteolytic reactions and involves different factors. There are two coagulation pathways, including intrinsic and extrinsic mechanisms, which converge by the formation of factor Xa.
Thi Bich Van Pham, Minh Hao Hoang
doaj   +1 more source

Ischemic stroke and dose adjustment of oral Factor Xa inhibitors in patients with atrial fibrillation [PDF]

open access: yes, 2023
Background Oral Factor Xa inhibitors for the prevention of stroke in atrial fibrillation require dose adjustment based on certain clinical criteria, but the off-label use of the reduced doses is common. Methods
Marsch, Armin   +9 more
core   +2 more sources

Anticoagulation by factor Xa inhibitors [PDF]

open access: yesJournal of Thrombosis and Haemostasis, 2010
Therapeutic agents that regulate blood coagulation are critical to the management of thrombotic disorders, with the selective targeting of factor (F) Xa emerging as a promising approach.To assess anticoagulant strategies targeting FXa.A deterministic computational model of tissue factor (Tf)-initiated thrombin generation and two empirical experimental ...
T, Orfeo   +4 more
openaire   +2 more sources

Edoxaban: an update on the new oral direct factor Xa inhibitor. [PDF]

open access: yes, 2014
Edoxaban is a once-daily oral anticoagulant that rapidly and selectively inhibits factor Xa in a concentration-dependent manner. This review describes the extensive clinical development program of edoxaban, including phase III studies in patients with ...
Camm, AJ   +3 more
core   +1 more source

Evolutionary dynamics on a regular networked structured and unstructured multi‐population

open access: yesInternational Journal of Robust and Nonlinear Control, EarlyView., 2023
Abstract In this paper, we study collective decision‐making in a multi‐population framework, where groups of individuals represent whole populations that interact by means of a regular network. Each group consists of a number of players and every player can choose between two options.
Wouter Baar   +2 more
wiley   +1 more source

PREDICTORS OF THE RISK OF HEMORRHAGIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING LONGTERM THERAPY WITH DIRECT ORAL ANTICOAGULANTS

open access: yesРациональная фармакотерапия в кардиологии, 2017
Aim. To study the initial disorders in the coagulation system, as factors influencing the development of bleeding during anticoagulant therapy with direct oral anticoagulants (DOAC).Material and methods.
A. А. Sokolova   +4 more
doaj   +1 more source

Efficacy and Toxicity of Factor Xa Inhibitors

open access: yesJournal of Pharmacy & Pharmaceutical Sciences, 2013
Venous thromboembolism (VTE) is a serious disease that is often neglected, and effective and safe antithrombotic treatments are a public health priority.
Maryna Bondarenko   +4 more
doaj   +1 more source

Direct thrombin inhibitors and factor Xa inhibitors for atrial fibrillation [PDF]

open access: yes, 2017
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness of direct thrombin inhibitors and factor Xa inhibitors on clinical outcomes in patients with ...
Tracy W Tai   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy